Triterpenoid-rich loquat leaf extract induces growth inhibition and apoptosis of pancreatic cancer cells through altering key flux ratios of glucose metabolism
Loquat leaf extract (LLE) is a mixture rich in terpenoids, and has broad biological activities including the inhibition of cancer cell growth. The exact metabolic mechanism of this growth inhibiting effect is not known.
We investigated the cellular metabolic effect of LLE, and ursolic acid (UA) on pancreatic cancer cells using a 13C carbon tracing technology.
MIA PaCa-2 cells were cultured in medium containing [1, 2 13C2]-glucose in the presence of either LLE (50 µg/ml), UA (50 µM), or metformin (1 mM). The mass isotopomer distribution of glucose, lactate, ribose, glutamate and palmitate in medium was determined. Based on the mass isotopomer distribution in metabolites we were able to determine individual 13C enrichment (∑M × n) and the minimum fraction of new synthesis (1-M0) in each metabolite. Several flux ratios of energy metabolic pathways were calculated from the mass isotopomer ratios of these metabolites.
We found that tumor viability was suppressed by LLE and UA in a dose dependent manner, and the tumor-inhibiting effect was associated with the changes in oxidative/non-oxidative pentose (Ox/Non-ox) and pyruvate dehydrogenase/isocitrate dehydrogenase (PDH/ICDH) flux ratios resulting in decreased new syntheses of ribose and fatty acids.
Metabolic homeostasis (balance of fluxes) in cancer cells is maintained through the regulation of metabolic fluxes by oncogenes and tumor-suppressor genes. Treatment of MIA PaCa-2 cells by LLE, UA and metformin likely altered key metabolic flux ratios affecting metabolic homeostasis required for energy and macromolecular production in tumor growth.
KeywordsLoquat Triterpenoid MIA PaCa-2 cells Tracer-based metabolomics Mass isotopomer profile
Loquat leaf extract
This work was supported by the Hirshberg Foundation for Pancreatic Cancer Research and by the National Institutes of Health (P01AT003960).
Compliance with ethical standards
Conflict of interest
The authors have no conflict of interest to disclose.
Research involving human and animals rights
This research did not involve human or animal subjects.
- Boros, L. G., Cascante, M., & Lee, W. N. (2002a). Stable isotope-based dynamic metabolic profiling in disease and health: Tracer methods and applications. Dordrecht: Kluwer Academic Publishers.Google Scholar
- Filosa, S., et al. (2003). Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. The Biochemical Journal, 370, 935–943. doi: 10.1042/BJ20021614.CrossRefPubMedPubMedCentralGoogle Scholar
- Harris, D. M., Li, L., Chen, M., Lagunero, F. T., Go, V. L., & Boros, L. G. (2012). Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75. Metabolomics, 8, 201–210. doi: 10.1007/s11306-011-0300-9.CrossRefPubMedGoogle Scholar
- Menendez, J. A., & Lupu R. (2004). Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells. Arch Immunol Ther Exp 52, 414–426.Google Scholar
- Yu, M., et al. (2015). Metabolic phenotypes in pancreatic cancer. PLoS One 10, doi: 10.1371/journal.pone.0115153.